AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HIV vaccine vectors expressing vaccinia virus IL-15 induce cellular immunity.

Vaccine Weekly

| May 14, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 MAY 14 - (NewsRx.com & NewsRx.net) -- Co-administration of HIV vaccine vectors with vaccinia viruses expressing IL-15, but not IL-2, induced long-lasting cellular immunity.

"Vaccine efficacy is determined largely by cellular and humoral immunity as well as long-lasting immunological memory. IL-2 and IL-15 were evaluated in vaccinia vectors expressing HIV gp160 for the establishment of an effective vaccine strategy. Both IL-2 and IL-15 in the vaccinia vector induced strong and long-lasting antibody-mediated immunity as well as a short-term cytotoxic T cell response against HIV gp120," scientists in the United States report.

"In addition, IL-15 also supported robust CD8+ T cell-mediated long-term immunity, whereas the CD8+ T cell-mediated immunity induced by IL-2 was short-lived," said SangKon Oh and collaborators at the National Cancer Institute and Johns Hopkins University. "Moreover, we found that the cytokine milieu at the time of priming had surprisingly persistent effects on the character of the memory CD8 T cells long afterward with respect ...

Related articles from newspapers, magazines, journals, and more
Science, social issues hamper development of HIV vaccine. (Duke University)
Newspaper article from: AIDS Weekly May 31, 1993 700+ words
...preventive and therapeutic HIV vaccine research, in providing...research, in resolving HIV vaccine liability issues...also co-chairs the National Academy of Sciences Institute...Infectious Diseases HIV vaccine working group, a collaboration...
Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor's...
Press release article from: Business Wire October 17, 2008 700+ words
...Using Electroporation to Test Preventive HIV Vaccine SAN DIEGO -- Ichor Medical Systems...tolerability data for a Phase I preventive HIV vaccine clinical trial being conducted at the...enhance delivery of the ADVAX DNA-based HIV vaccine developed by the Aaron Diamond AIDS...
ViroLogic's Entry Assay May Accelerate HIV Vaccine Development According to...
Press release article from: PR Newswire March 18, 2003 700+ words
...s issue of the Proceedings of the National Academy of Sciences (PNAS) suggest that its...may have important implications for HIV vaccine research, which in recent years has...companies are currently engaged in HIV vaccine research, as well as the National...
Preliminary Phase I safety data for preventive HIV vaccine delivered by Ichor's...
News wire article from: Chemical Business Newsbase October 17, 2008 700+ words
...data for a Phase I preventive HIV vaccine clinical trial being conducted...delivery of the ADVAX DNA-based HIV vaccine developed by the Aaron Diamond...published in the Proceedings of the National Academy of Sciences. The groups hope...
Broadly proactive HIV vaccine possible.
News wire article from: UPI NewsTrack May 30, 2007 700+ words
...48 strains of HIV-1 tested. The scientists said the results show it is possible to elicit a broad-spectrum HIV antibody response. The study appears in the early online edition of the Proceedings of the National Academy of Sciences.
Scripps gets a jump on HIV vaccine.(Research News)
Magazine article from: Bioscience Technology March 1, 2008 700+ words
...successfully tested aspects of it. Their study, which appeared online the week of Feb. 25 in the Proceedings of the National Academy of Sciences, may reenergize attempts to create a preventive/therapeutic vaccine against HIV, say the authors. The...
From rabies virus to anti-HIV vaccine.(Brief Article)
Magazine article from: Science News N.S. April 8, 2000 700+ words
...that such a rabies-based vaccine might thwart HIV, Schnell says. The study appears in the March 28 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. Other experimental HIV vaccines made of viruses carrying foreign genes tend to slay the cells they invade...
CytRx-Licensed RIP 140 Research Published in Proceedings of the National...
Press release article from: PR Newswire June 10, 2004 700+ words
...Proceedings of the National Academy of Sciences. On...Proceedings of the National Academy of Sciences is a...Proceedings of the National Academy of Sciences (PNAS...to a DNA-based HIV vaccine technology. The...
Sabin: AIDS vaccines won't work. (Albert Sabin) (National Academy of Sciences)
Newspaper article from: AIDS Weekly DeNoon, Daniel J. October 12, 1992 700+ words
National Academy of Sciences There is no basis for...Writing in the Proceedings of the National Academy of Sciences, Albert B. Sabin argues...human beings or for expecting that any HIV vaccine could be effective in human beings...
Induction of antibodies to the envelope protein of the human immunodeficiency...
Newspaper article from: AIDS Weekly August 5, 1991 700+ words
SOURCE: Proceedings of the National Academy of Sciences, July 1991;88(13):5645-5649. Anti...the possibility of using this approach to develop an anti-HIV vaccine. They used synthetic peptides corresponding to HIV*1 amino...
For more facts and information, see all results

Source: HighBeam Research, HIV vaccine vectors expressing vaccinia virus IL-15 induce cellular...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA